The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Deferasirox Tablet Market Research Report 2025
Synopsis
Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.
The global Deferasirox Tablet market was valued at US$ 323 million in 2023 and is anticipated to reach US$ 113.8 million by 2030, witnessing a CAGR of -5.7% during the forecast period 2024-2030.
The Exjade market is driven by the increasing prevalence of iron overload conditions, such as transfusional hemosiderosis in patients receiving regular blood transfusions. Exjade, a medication containing deferasirox, is used to manage iron overload by chelating excess iron and promoting its elimination from the body. The drug's efficacy in preventing iron-related complications has contributed to its growing adoption in the treatment of thalassemia and other transfusion-dependent disorders. Moreover, advancements in medical research and improved patient access have further propelled market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize dosing and monitoring strategies. Overcoming these challenges and expanding access to affordable and safe treatments will be crucial for the sustained growth of the Exjade market.
This report aims to provide a comprehensive presentation of the global market for Deferasirox Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Deferasirox Tablet.
Report Scope
The Deferasirox Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Deferasirox Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Deferasirox Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Segment by Type
125mg
250mg
500mg
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Deferasirox Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Deferasirox Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.
The global Deferasirox Tablet market was valued at US$ 323 million in 2023 and is anticipated to reach US$ 113.8 million by 2030, witnessing a CAGR of -5.7% during the forecast period 2024-2030.
The Exjade market is driven by the increasing prevalence of iron overload conditions, such as transfusional hemosiderosis in patients receiving regular blood transfusions. Exjade, a medication containing deferasirox, is used to manage iron overload by chelating excess iron and promoting its elimination from the body. The drug's efficacy in preventing iron-related complications has contributed to its growing adoption in the treatment of thalassemia and other transfusion-dependent disorders. Moreover, advancements in medical research and improved patient access have further propelled market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize dosing and monitoring strategies. Overcoming these challenges and expanding access to affordable and safe treatments will be crucial for the sustained growth of the Exjade market.
This report aims to provide a comprehensive presentation of the global market for Deferasirox Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Deferasirox Tablet.
Report Scope
The Deferasirox Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Deferasirox Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Deferasirox Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Segment by Type
125mg
250mg
500mg
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Deferasirox Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Deferasirox Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Deferasirox Tablet Market Overview
1.1 Product Overview and Scope of Deferasirox Tablet
1.2 Deferasirox Tablet Segment by Type
1.2.1 Global Deferasirox Tablet Market Value Comparison by Type (2024-2030)
1.2.2 125mg
1.2.3 250mg
1.2.4 500mg
1.3 Deferasirox Tablet Segment by Application
1.3.1 Global Deferasirox Tablet Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Deferasirox Tablet Market Size Estimates and Forecasts
1.4.1 Global Deferasirox Tablet Revenue 2019-2030
1.4.2 Global Deferasirox Tablet Sales 2019-2030
1.4.3 Global Deferasirox Tablet Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Deferasirox Tablet Market Competition by Manufacturers
2.1 Global Deferasirox Tablet Sales Market Share by Manufacturers (2019-2024)
2.2 Global Deferasirox Tablet Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Deferasirox Tablet Average Price by Manufacturers (2019-2024)
2.4 Global Deferasirox Tablet Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Deferasirox Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Deferasirox Tablet, Product Type & Application
2.7 Deferasirox Tablet Market Competitive Situation and Trends
2.7.1 Deferasirox Tablet Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Deferasirox Tablet Players Market Share by Revenue
2.7.3 Global Deferasirox Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Deferasirox Tablet Retrospective Market Scenario by Region
3.1 Global Deferasirox Tablet Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Deferasirox Tablet Global Deferasirox Tablet Sales by Region: 2019-2030
3.2.1 Global Deferasirox Tablet Sales by Region: 2019-2024
3.2.2 Global Deferasirox Tablet Sales by Region: 2025-2030
3.3 Global Deferasirox Tablet Global Deferasirox Tablet Revenue by Region: 2019-2030
3.3.1 Global Deferasirox Tablet Revenue by Region: 2019-2024
3.3.2 Global Deferasirox Tablet Revenue by Region: 2025-2030
3.4 North America Deferasirox Tablet Market Facts & Figures by Country
3.4.1 North America Deferasirox Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Deferasirox Tablet Sales by Country (2019-2030)
3.4.3 North America Deferasirox Tablet Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Deferasirox Tablet Market Facts & Figures by Country
3.5.1 Europe Deferasirox Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Deferasirox Tablet Sales by Country (2019-2030)
3.5.3 Europe Deferasirox Tablet Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Deferasirox Tablet Market Facts & Figures by Country
3.6.1 Asia Pacific Deferasirox Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Deferasirox Tablet Sales by Country (2019-2030)
3.6.3 Asia Pacific Deferasirox Tablet Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Deferasirox Tablet Market Facts & Figures by Country
3.7.1 Latin America Deferasirox Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Deferasirox Tablet Sales by Country (2019-2030)
3.7.3 Latin America Deferasirox Tablet Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Deferasirox Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Deferasirox Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Deferasirox Tablet Sales by Country (2019-2030)
3.8.3 Middle East and Africa Deferasirox Tablet Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Deferasirox Tablet Sales by Type (2019-2030)
4.1.1 Global Deferasirox Tablet Sales by Type (2019-2024)
4.1.2 Global Deferasirox Tablet Sales by Type (2025-2030)
4.1.3 Global Deferasirox Tablet Sales Market Share by Type (2019-2030)
4.2 Global Deferasirox Tablet Revenue by Type (2019-2030)
4.2.1 Global Deferasirox Tablet Revenue by Type (2019-2024)
4.2.2 Global Deferasirox Tablet Revenue by Type (2025-2030)
4.2.3 Global Deferasirox Tablet Revenue Market Share by Type (2019-2030)
4.3 Global Deferasirox Tablet Price by Type (2019-2030)
5 Segment by Application
5.1 Global Deferasirox Tablet Sales by Application (2019-2030)
5.1.1 Global Deferasirox Tablet Sales by Application (2019-2024)
5.1.2 Global Deferasirox Tablet Sales by Application (2025-2030)
5.1.3 Global Deferasirox Tablet Sales Market Share by Application (2019-2030)
5.2 Global Deferasirox Tablet Revenue by Application (2019-2030)
5.2.1 Global Deferasirox Tablet Revenue by Application (2019-2024)
5.2.2 Global Deferasirox Tablet Revenue by Application (2025-2030)
5.2.3 Global Deferasirox Tablet Revenue Market Share by Application (2019-2030)
5.3 Global Deferasirox Tablet Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Deferasirox Tablet Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Deferasirox Tablet Product Portfolio
6.1.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Deferasirox Tablet Industry Chain Analysis
7.2 Deferasirox Tablet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Deferasirox Tablet Production Mode & Process
7.4 Deferasirox Tablet Sales and Marketing
7.4.1 Deferasirox Tablet Sales Channels
7.4.2 Deferasirox Tablet Distributors
7.5 Deferasirox Tablet Customers
8 Deferasirox Tablet Market Dynamics
8.1 Deferasirox Tablet Industry Trends
8.2 Deferasirox Tablet Market Drivers
8.3 Deferasirox Tablet Market Challenges
8.4 Deferasirox Tablet Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
